CDIOW
Cardio Diagnostics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.02
+10.42%Year over year
Reported trailing growth
- Revenue
- -25.9%
- EBITDA
- -5.5%
- EBIT
- -3.6%
- EPS
- +21.8%
- Free cash flow
- -4.0%
- Operating cash flow
- -2.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +149.9%
- EBITDA
- +24.8%
- EBIT
- +22.5%
- Net income
- +22.5%
- EPS
- +60.1%
- Free cash flow
- -9.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026